ESR2 and prostate carcinoma: This was consistent with the findings reported by Chan who stated that ERβ was abnormally expressed in various estrogen-dependent tumors (such as breast cancer and prostate cancer) and resulted in a reduction in cell movement and invasion, leading to increased tumor cell apoptosis (39).